Status:
UNKNOWN
PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs
Lead Sponsor:
Chelsea and Westminster NHS Foundation Trust
Conditions:
Coronavirus
Corona Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
PHENOTYPE is an investigator-led, observational cohort study which aims to explore the long-term outcomes of patients with COVID-19 infection and to identify potential risk factors and biomarkers that...
Detailed Description
In 2019, a novel coronavirus, SARS-CoV-2 was first identified in Wuhan, China. SARS-CoV-2 infection, denominated COVID-19, causes a predominantly respiratory illness, which varies from mild respirator...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Aged 18 years or older
- Confirmed COVID-19 infection (as per national guidelines)
- Attending follow-up outpatient visit post hospital attendance with COVID-19 infection
- Exclusion Criteria
- There are no specific exclusion criteria
Exclusion
Key Trial Info
Start Date :
June 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04459351
Start Date
June 19 2020
End Date
June 1 2023
Last Update
August 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chelsea and Westminster Hospital
London, United Kingdom, SW10 9NH